Publication Criteria and Requirements for Studies on Protein Kinase Inhibitors─What Is Expected?
Stefan Laufer, Jürgen Bajorath, Matthias Gehringer, Nathanael S. Gray, Stephen V. Frye, Craig W. Lindsley
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVEditorialNEXTPublication Criteria and Requirements for Studies on Protein Kinase Inhibitors─What Is Expected?("It is pretty easy to make a bad kinase inhibitor")Stefan LauferStefan LauferDepartment of Pharmaceutical and Medicinal Chemistry, Eberhard-Karls-Universität Tübingen, D-72076 Tübingen, GermanyMore by Stefan Lauferhttps://orcid.org/0000-0001-6952-1486, Jürgen BajorathJürgen BajorathDepartment of Life Science Informatics and Data Science, B-IT, Rheinische Friedrich-Wilhelms-Universität, D-53115 Bonn, GermanyMore by Jürgen Bajorathhttps://orcid.org/0000-0002-0557-5714, Matthias GehringerMatthias GehringerDepartment of Pharmaceutical and Medicinal Chemistry, Eberhard-Karls-Universität Tübingen, D-72076 Tübingen, GermanyMore by Matthias Gehringerhttps://orcid.org/0000-0003-0163-3419, Nathanael GrayNathanael GrayDepartment of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, United StatesMore by Nathanael Grayhttps://orcid.org/0000-0001-5354-7403, Stephen FryeStephen FryeCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United StatesMore by Stephen Fryehttps://orcid.org/0000-0002-2415-2215, and Craig W. LindsleyCraig W. LindsleyDepartment of Pharmacology, Department of Chemistry, and Vanderbilt Institute of Chemical Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232, United StatesMore by Craig W. Lindsleyhttps://orcid.org/0000-0003-0168-1445Cite this: J. Med. Chem. 2022, 65, 10, 6973–6974Publication Date (Web):May 5, 2022Publication History Published online5 May 2022Published inissue 26 May 2022https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00623https://doi.org/10.1021/acs.jmedchem.2c00623editorialACS PublicationsCopyright © Published 2022 by American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views7536Altmetric-Citations10LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (565 KB) Get e-AlertscloseSUBJECTS:Assays,Inhibition,Inhibitors,Medicinal chemistry Get e-Alerts